Curis Lifesciences Schedules Board Meeting for H1 FY27 Results and IPO Proceeds Review
Curis Lifesciences Ltd 路 Intimation 路 11 Nov 2026, 5:30 am
Curis Lifesciences Schedules Board Meeting for H1 FY27 Results and IPO Proceeds Review Curis Lifesciences Limited has scheduled its Board of Directors meeting on 11th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the half year ended 30th Sep'26. The board will also review the utilization report of Initial Public Offering proceeds and evaluate any statements of deviation or variation under SEBI LODR Regulation 32. In accordance with insider trading regulations, the trading window for designated persons remains closed from 1st Oct'26 until 48 hours post-result declaration.
Original exchange filing (PDF)
More announcements from Curis Lifesciences Ltd
- Curis Lifesciences Limited has informed the Exchange regarding 'Standalone andconsolidated financials results for the half year ended on 30th September, 2026'. 路 16 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 11 Nov 2026
- Curis Lifesciences Limited has submitted to the Exchange, the standalone and consolidated financial results for the half year ended September 30, 2026. 路 11 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 11 Nov 2026
- Curis Lifesciences Limited has informed regarding Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Quarter and year ended on September 30, 2026 路 19 Oct 2026
- Curis Lifesciences Limited has submitted the Exchange a copy Srutinizers report of 10th Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results. 路 01 Oct 2026
- CURIS: Curis Lifesciences Limited has informed the Exchange regarding Proceedings of 10thAnnual General Meeting held on September 29, 2026. 路 30 Sept 2026
- Curis Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026 路 08 Sept 2026
